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Original Article
Vertebral Osteomyelitis: A Mortality
Analysis Comparing Surgical
and Conservative Management
Spogmai Zadran, MD1, Peter Heide Pedersen, MD1 ,
and Søren Eiskjær, MD1
Abstract
Study Design: Retrospective cohort study.
Objectives: To compare the mortality between patients treated for vertebral osteomyelitis (VO) with either surgical or
conservative management and to construct a predictive model for mortality after VO.
Methods: All patients with a diagnosis of VO in Region North Denmark from 2004 to 2014 were followed for at least 2 years or
until death. They were all treated according to a standardized guideline for the choice of treatment modality. Nineteen dichotomized
variables with possible influence on the mortality were registered for all patients in the study. LASSO (least absolute shrinkage and
selection operator) penalized Cox regression analysis was used to build a predictive model for 2-year survival after VO.
Results: A total of 125 patients were eligible for inclusion, mean age 67 years, 36 women. 75 were treated surgically. Twenty-one
patients were dead 2 years after the diagnosis. Kaplan-Meier estimate of 2-year survival was 0.82 [0.75, 0.88]. Any difference in
mortality between surgically and conservatively treated patients was nonsignificant at 1 and 2 years (univariate Cox regression
analysis). Significant factors included in the predictive model after LASSO penalized Cox regression analysis was Charlson
Comorbidity Index (CCI), cardiovascular disease, C-reactive protein (CRP) normalization, thoracic infection, and Karnofsky
score. The area under the curve (AUC) for the predictive model ranged from 0.74 to 0.77.
Conclusion: Patients undergoing surgical management for vertebral osteomyelitis according to standardized and agreed-upon
guidelines had no higher mortality than those allocated to conservative treatment. The predictive model included 5 variables
associated with an increased mortality: CCI, CRP normalization, cardiovascular disease, thoracic infection, and Karnofsky score.
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Introduction
Vertebral osteomyelitis (VO) is a severe condition associated
with high mortality and risk of permanent neurological deficits
and chronic pain.1,2 There is an increased short- and long-term
mortality in VO patients compared with the background pop-
ulation.3 The overall incidence of VO in Denmark increased
from 2.2/100 000 to 5.8/100 000 in the years 1995-2008.4 The
increased incidence in Denmark could be real or the results of
better diagnostics (magnetic resonance imaging [MRI] avail-
ability in Denmark has increased considerably the past 10-15
years) and workup.
In general, the possible reasons for the increased incidence
of VO depend on a number of causes, such as: better diagnostic
techniques (MRI and polymerase chain reaction), increased
population longevity, more immunocompromised people and
increased use of intravenous (IV) drugs and indwelling
devices.5-7 The most common bacterial organisms are Staphy-
lococcus aureus, followed by gram-negative bacilli and Strep-
tococcus/enterococci. The routes of infection may be
hematogenous, contiguous, postoperative, or posttraumatic.8
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Predisposing factors such as diabetes mellitus, malnutrition,
substance abuse (alcohol/drug users), sickle cell anemia,
immunosuppressive conditions (HIV, steroid users), tumors,
renal failure, and septicemia may aggravate the final outcome
of spondylodiscitis.
Diagnosing VO may be challenging due to vague symptoms
such as pain, fever, night sweats, anemia, loss of weight, and
malaise.9 Late diagnosis can result in general multiple organ
failure and epidural abscesses.10 On average, the diagnostic
delay from onset of symptoms to diagnosis is approximately
2 to 6 months.11 Management of VO is either medical treatment
alone (conservative treatment) or a combination of medical
treatment and surgery. To date, conservative treatment remains
as first-line treatment of VO.2 The indication for surgery is not
entirely evidence based.11
The empirical indications for surgery are mechanical
instability, abscess formation, compression of spinal cord or
cauda equina, progressive neurologic compromise, intolerable
pain, or failed nonsurgical therapy. Surgical intervention is
followed by antibiotic treatment equivalent to conservative
therapy.12,13
Surgery for VO is often major surgery. It is questionable if
these rather frail elderly patients will fare better with surgical
intervention especially as the candidates for surgery are those
with the most advanced disease—bearing in mind that the mor-
tality is high for VO.
The present study is a retrospective case cohort study from a
single center, Aalborg University Hospital, Denmark. The aim
of the study was to evaluate the mortality outcome of surgical
treatment of VO at our institution compared with patients
treated conservatively. Second, to evaluate factors influencing
the mortality of patient with VO by predictive modeling.
Materials and Methods
All patients with a diagnosis of VO in Region North Denmark
(population 580 000), from the first of January 2004 until the
first of January 2014 and treated at Aalborg University Hospi-
tal, were included in the study. The unique 10-digit personal
identification number assigned to all Danish citizens at birth
was used to avoid multiple registration and to track individuals
over time. The Danish National Registry of Patients was
searched using the aforementioned criteria and the following
ICD-10 (International Classification of Diseases, 10th Revi-
sion) diagnosis codes: DM462, DM463A, DM464, DM465A,
DM490, DM491, DM492, DM493. A retrospective review of
the electronic patient record (Clinical Suite version 18.0.4.0)
for each patient was performed. The diagnosis was confirmed
by a combination of the clinical history, C-reactive protein
(CRP) elevation, MRI findings, histological findings, or posi-
tive tissue cultures. Tissue diagnostics was performed in all the
surgically treated cases and in the conservatively treated cases
except in cases where blood cultures were positive. The time of
death was retrieved form the Danish Register of Causes of
Death for those who died during the follow-up period.
Exclusion criteria were unconfirmed VO diagnosis, incom-
plete data, or treatment not following standardized guidelines,
age less than 18 years, patients with relapse, VO after lumbar
spine surgery and a missing or normal CRP level at time of
diagnosis (<10 mg/L). The chosen censoring date was March
9, 2017.
The study was approved by the local institutional review
board and by the Danish Data Protection Agency. According
to Danish law, no approval by the Medical Ethics Committee is
required for observational studies.
The aforementioned search resulted in a cohort of 159
patients, and 125 patients fulfilled the inclusion criteria (Figure
1). The indications for surgery was mechanical instability, epi-
dural abscess formation, paravertebral abscess not suitable for
ultrasound guided drainage, neurologic deficit, compression of
spinal cord or cauda equina, intolerable pain, or failed nonsur-
gical therapy. Standard surgical treatment consisted of debride-
ment followed by pulsatile lavage with 1 to 3 L of isotonic
saline, circumferential fusion with posterior instrumentation,
bone grafting (posterolateral and interbody), and locally
instilled antibiotics. IV antibiotics followed surgery for 10 to
14 days and oral antibiotics followed IV antibiotics for a dura-
tion of 10 weeks—all in all 3 months of antibiotic therapy.
Standard conservative therapy consisted of IV antibiotics
for 10 to 14 days and oral antibiotics for a duration of 10 weeks
(also for a total 3 months of antibiotic therapy). A lumbar or
thoracolumbar orthosis was used as part of the pain treatment in
most cases.
All patients were followed for at least 2 years from the date
of diagnosis or until death. No patients were lost to follow-up.
Nineteen variables were registered from the electronic
patient record for the 125 patients (Table 1). The data set was
complete in all cases. All 19 variables were dichotomized. Age
was dichotomized with cut point of 60 years. Charlson Comor-
bidity Index (CCI)14 with cut point 1 (at the most 1 comorbid-
ity). Frankel grade15 with cut point grade E (normal
neurology). Karnofsky score16 with cut point 80 (able to work).
CRP level was dichotomized with cut point 30 mg/L 14 days
after treatment start.
Figure 1. Flowchart for the 125 patients eligible for the study.
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The continuous variables are presented as mean and standard
deviations (SD) and dichotomous parameters as frequencies and
percentages. Continuous variables were compared using the
unpaired Student’s t test. The chi-square test was used to assess
differences in the dichotomous variables (P < .05).
The statistical methods included univariate cox regression
(likelihood ratio test) for all variables. Multicollinearity was
investigated using the variance inflation factor (VIF; a value
>4 was considered index of multicollinearity).
Because of the sparse data (large number of candidate pre-
dictors and few events) a multivariate L1 (least absolute shrink-
age and selection operator–LASSO) penalized Cox regression
model was used to build a predictive model for 2-year survival
after diagnosis of vertebral osteomyelitis. We chose 2 years as
censoring date because this is an agreed-upon follow-up time in
clinical research.17 The LASSO model automatically performs
variable selection by shrinking the variables not related to out-
come to zero. The LASSO method is also able to handle col-
linearity issues. The shrinkage penalty is weighted based on a
tuning parameter l. The optimal l value was determined using
10-fold internal cross validation. Predicted survival profiles for
specific patients were constructed from the LASSO model to
illustrate the model’s functionality. The model performance
was evaluated with the area under the curve (AUC) at different
time points.
The statistical analyses were all conducted with R statisti-
cal software version 3.3.3 (R Foundation for Statistical Com-
puting, Vienna, Austria) and the packages “survival,”
“penalized,”17 and “hdnom.”
Results
The characteristics of the 125 patients according to the type of
treatment are presented in Table 1. For the variables IV drug
abuse, abscess formation, and CRP normalization there was a
significantly higher proportion of patients treated surgically
(chi-square test). The coding of the variables is given in par-
entheses in Table 1. This coding was used in all subsequent
Table 1. Variables, Coding, and Distribution According to Treatment.
Variable Name and Coding Conservative (0), n (%) Surgery (1), n (%) Total, n (%) P
Male (0) 36 (72) 53 (71) 89 (71) 1
Female (1) 14 (28) 22 (29) 36 (29)
Age >60 years (1) 37 (74) 55 (73) 92 (74) 1
Age 60 years (0) 13 (26) 20 (27) 33 (26)
Diabetes (1) 6 (12) 17 (23) 23 (18) .2
No diabetes (0) 44 (88) 58 (77) 102 (87)
Cardiovascular disease (1) 16 (32) 25 (33) 41 (33) 1
No cardiovascular disease (0) 34 (68) 50 (67) 84 (67)
Lung disease (1) 5 (10) 6 (8) 11 (9) .95
No lung disease (0) 45 (90) 69 (92) 114 (91)
Cancer (1) 6 (12) 12 (16) 18 (14) .72
No cancer (1) 44 (88) 63 (84) 107 (86)
Renal disease (1) 3 (6) 7 (9) 10 (8) .74
No renal disease (0) 47 (94) 68 (91) 115 (92)
Intravenous drug abuser (1) 0 (0) 8 (11) 8 (6) .04
Not an intravenous drug abuser (0) 50 (100) 67 (89) 117 (94)
Alcoholic (1) 9 (18) 11 (15) 20 (16) .8
Not an alcoholic (0) 41 (82) 64 (85) 105 (84)
Charlson Comorbidity Index > 1 (1) 23 (46) 45 (60) 57 (46) .18
Charlson Comorbidity Index  1 (0) 27 (54) 30 (40) 68 (54)
Frankel grade not E (1) 19 (38) 33 (44) 52 (42) .63
Frankel grade E (0) 31 (62) 42 (56) 73 (59)
Karnofsky score <80 (1) 24 (48) 32 (43) 56 (45) .68
Karnofsky score 80 (0) 26 (52) 43 (57) 69 (55)
Endocarditis (1) 8 (16) 10 (13) 18 (14) .88
No endocarditis (0) 42 (84) 65 (87) 107 (86)
Paravertebral or epidural abscess (1) 13 (26) 48 (64) 61 (49) .00007
No abscess (0) 37 (74) 27 (36) 64 (51)
Vertebral body destruction (1) 2 (4) 11 (15) 13 (10) .11
No vertebral body destruction (0) 48 (96) 64 (85) 112 (90)
Thoracic spine infection (1) 13 (26) 22 (29) 35 (28) .84
Not thoracic spine infection (0) 37 (74) 53 (71) 90 (72)
Staphylococcus aureus (1) 17 (34) 24 (32) 41 (33) .97
No Staphylococcus aureus (0) 33 (66) 51 (68) 84 (67)
C-reactive protein 30 mg/L 14 days after treatment start (0) 32 (64) 28 (37) 60 (48) .006
C-reactive protein >30 mg/L 14 days after treatment start (1) 18 (36) 47 (63) 65 (52)
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survival analysis. A coding of zero and a positive regression
coefficient e.g. a coding of zero for CRP normalization 14
days signifies that patients with CRP normalized in less than or
equal to 14 days will have a lesser risk of dying in a 1- or 2-year
span. The mean age between the conservatively and surgically
treated patients did not differ significantly (67.24 and 67.25
years, P ¼ .99). Age range was 38-92 years. First quartile 59
years. The bacterial etiology was unknown in 17 cases, caused
by Staphylococcus aureus in 41 cases, Staphylococcus epider-
mis in 3 cases, Streptococcus species in 14 (hemolytic strepto-
cocci in 6 cases), Escherichia coli in 12 cases, enterococci in 9
cases, and by diverse and rare bacteria in 29 cases. Seventeen
and 21 patients were dead after 1 and 2 years, respectively.
Kaplan-Meier estimate of 1- and 2-year survival was 0.86
(95% confidence interval [CI] 0.79-0.91) and 0.824 (95% CI
0.745-0.880), respectively. The survival curve for all 125
patients is presented in Figure 2. The results of the conven-
tional univariate Cox regression are shown in Table 2—like-
lihood ratio test. Only the P values for cardiovascular disease,
CCI, and CRP normalization were less than or equal to .05. The
95% CIs of the Kaplan-Meier curves for the surgically treated
compared with the conservatively treated overlapped at any
time point (Figure 3). The VIF was less than 1.8 in all cases
indicating no evidence of multicollinearity in the model. The
cross-validated log partial likelihood for a range of values of
lambda (Figure 4). The value of lambda producing the opti-
mum goodness of fit was 2.49. The path of the coefficients for
a range of values of lambda is presented in Figure 5. The 5
nonzero coefficients for CCI, CRP normalization, cardiovas-
cular disease, thoracic spine infection, and Karnofsky score
(Table 3). A subset analysis on the surgically and conserva-
tively treated patients was undertaken but no nonzero vari-
ables were detected for these relatively small subgroups. The
magnitude of these parameter estimates is not intended to be
interpreted in terms of hazard ratios as the LASSO procedure
has shrunken them and neither is it possible to calculate the
confidence intervals for the penalized coefficients with cer-
tainty.17,18 However, the coefficients can be used to calculate
the predicted survival profile for specific patients (Figure 6)
using the “predict” function in the R package penalized.19 The
predictive model had an acceptable discriminatory ability.
The AUC was 0.77 at 6 months, 0.74 at 1 year, and 0.74 at
2 years (Figure 7).
Discussion
The principal finding of this retrospective cohort study stands
in contrast to the general belief that surgical intervention in
patients is directly associated with an increased mortality com-
pared with those treated conservatively.20 The fact that the
mortality rate for those treated surgically does not differ sig-
nificantly from the other group, is surprising. Especially when
considering that the surgically managed patients had higher
CCI scores, namely, they were frailer. The surgically treated
also had more severe VO as most of them had epidural and/or
paravertebral abscess.
Figure 2. Overall survival for the 125 patients. Blue area indicates
95% confidence limits.
Table 2. Conventional Univariate Cox Regression Analysis.
Variable
Hazard
Ratio 95% CI P
Sex 1.31 0.53-3.26 .56
Age 2.28 0.67-7.73 .14
Treatment 1.73 0.67-4.46 .24
Diabetes 1.93 0.75-4.96 .20
Cardiovascular disease 2.93 1.23-6.95 .015
Lung disease 0.5 0.07-3.75 .45
Cancer 1.45 0.49-4.32 .52
Renal disease 3.19 1.07-9.48 .07
Intravenous drug abuse 0.71 0.10-5.29 .72
Alcoholic 1.34 0.45-3.99 .61
Charlson Comorbidity Index 3.98 1.34-11.85 .005
Frankel grade 1.64 0.70-3.86 .26
Karnofski score 1.79 0.75-4.24 .19
Endocarditis 1 0.29-3.40 .99
Paravertebral or epidural abscess 0.93 0.39-2.18 .86
Vertebral body destruction 1.47 0.43-4.99 .55
Thoracic spine infection 2.12 0.89-5.04 .09
Staphylococcus aureus 1.03 0.42-2.56 .94
C-reactive protein 30 mg/L 14 days
after treatment start
3.28 1.20-8.96 .01
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A major strength of this study lies in the fact that VO treat-
ment for an entire geographically defined population group
over a 10-year period has been described and evaluated. No
patients were lost to follow-up and our data set was complete.
All VO patients were treated at the same medical center
according to the same algorithm agreed upon by both the
Department of Infectious Diseases and the Department of
Orthopedic Surgery. Patient data was acquired directly from
the medical records and not from the national registers except
for the mortality data and initial data on diagnosis which both
rely on the unique 10-digit number every person of Danish
nationality receives at birth.
The number of events per variable almost equaled 1. How-
ever, the LASSO penalized Cox proportional hazards regres-
sion is the statistical method of choice under these
circumstances. Penalized regression helps avoiding overfitting
and allows for variable selection better than classical stepwise
regression.17,18 If the predictors are severely correlated pena-
lized regression has a tendency to select at random—selecting
one at random from a group of highly correlated predictors.18
The predictors in the current study were not highly corre-
lated—all with VIFs <1.8. We also believe that the predictors
were chosen based on well-founded clinical insight so that the
number of “noise predictors” were few or none. LASSO pena-
lized regression functions best when the number of noise
Figure 3. Kaplan Meier curves comparing conservative treatment and
surgery. Vertical lines indicate 95% confidence intervals.
Figure 4. Maximum lambda1.
Figure 5. Path of the standardized coefficient estimates over a range
of values of the LASSO constraint lambda1. The vertical gray line is the
optimal value of lambda, the same value as in Figure 4.
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predictors are few. We chose not to calculate standard errors
for the coefficients as these are not very meaningful for
strongly biased estimators such as the LASSO penalized
regression coefficients.18
Even though the discriminatory ability of the predictive
model was acceptable with an AUC between 0.70 and 0.80 one
must expect the discriminatory ability to decrease when applied
to new patients or patients with VO from another medical
center. However, we believe that the selected variables make
sense. CCI has been shown to be a strong predictor of mortality
in other studies1,21 and a CCI  2 was associated with higher
mortality in a study by Loibl et al.21 The Karnofsky score is
well correlated to frailty but was only a weak predictor in this
study. A modified frailty score was associated with a 30-day
postoperative mortality in patients with tuberculous spondylo-
discitis.22 Thoracic VO is an infection at the level of the spinal
cord which must be considered more severe than VO at the
level of the cauda equina (lumbar level). The findings by Appa-
lanaidu et al23 corroborate our findings—thoracic and thoraco-
lumbar infection indicated more severe disease. CRP
normalization will be delayed after surgery due to the surgical
trauma. But the decrease to a CRP level less than 30 mg/L also
depends on the CRP level at treatment start. Loibl et al21 has
shown that a CRP  100 mg/L at admission is associated with
an increased mortality in VO and our data somehow corrobo-
rates their findings as we did find that a normalization of CRP
in less than or equal to 14 days was associated with decreased
mortality (remember the coding in Table 1—zero coding indi-
cating normalization in 14 days). The initial CRP was not
recorded precisely at the start of treatment in all cases, thus it
was not possible to use this in the statistical analysis as a
complete data set is required. The requirement for a full data
set implicates that some other predictors might have been
omitted in the statistical analysis but nevertheless, we consider
the 19 variables important and relevant in this context.
There is in fact a risk that given a higher number of patients
we might have found a significant difference in mortality
between the 2 treatments, and the nonsignificant finding of
mortality difference could be a result of a type 2 error. How-
ever, even if there was to be a significant difference in mortal-
ity between the treatment groups, it would still be small, and
the results of our study would still be in favor of treating more
severe cases of VO with surgery even with some increase in
mortality. Besides helping reduce mortality for the severely ill,
other benefits of surgery are higher post-VO functional level
and less pain.2 Delaying a necessary surgical intervention is
associated with an increased mortality and morbidity.24
Table 3. Nonzero Coefficients From the LASSO Penalized Cox
Proportional Hazard Regression.
Variable Coefficient
Charlson Comorbidity Index 0.55
C-reactive protein normalization 0.45
Cardiovascular disease 0.30
Thoracic spine infection 0.18
Karnofsky score 0.07
Figure 6. Predicted survival profiles for patients 24 and 55.
Figure 7. Time-dependent AUC (area under the receiver operating
characteristic [ROC] curve) for the LASSO model. Solid line indicates
mean of the AUC and dashed line indicates the median of the AUC.
Darker interval indicates 25% and 75% quantiles of AUC. Lighter
interval indicate minimum and maximum of AUC.
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As has been stated in the introduction, different treatment
algorithms and approaches for the management of VO exist.2
Most studies have looked at the effect of medical or surgical
treatment and only a few studies have dealt with the direct
comparison of mortality between surgery and medical treatment,
most likely owing to the fact that the 2 groups are not easily
comparable without turning to relatively sophisticated statistical
methods. Surgery is usually the secondary choice of treatment
and reserved to patients with more severe symptoms or for those
not responding to conservative medical treatment alone.
In the present study, vertebral body destruction was not seen
significantly more often for the surgically treated patients
although there was a strong tendency (P ¼ .11). MRI is prob-
ably less effective in judging the extent of destruction and in
the authors’ opinion the clinical signs are more important—the
presence of excruciating pain when shifting position especially
when shifting from lying down to standing and vice versa is a
more pathognomonic sign for significant bony destruction.
The incidence of VO in this study of 2.74/100 000 is com-
parable to data from the literature, which is 2.2/100 000 to 5.8/
100 000.4,25
A comparison of mortality rates between the current study
and earlier studies is fraught with difficulties. The age distri-
bution will differ as some studies include children with zero
mortality. Many studies do not even report the 1- and 2-year
mortality rates of the population in question.
Mortality from VO at different time has been described with
some discrepancy ranging from 11% to 20% at 1 year.3,7,26
Kehrer et al3 reported a 1-year mortality of 20%, which seems
high when compared with our study and literature in general.
The characteristics of their study group was similar to ours,
though, lower CCI and comorbidities were reported compared
with our group. Brummerstedt et al27 reported a 1-year mortal-
ity of 18%. Our 1-year mortality rate corresponds very well to
the 1-year mortality in a large randomized controlled French
trial comparing 6 and 12 weeks of antibiotic treatment in
patients with VO (13%).28 The 2 studies mentioned above
included only patients treated conservatively and one cannot
help wondering if surgical intervention with the well-
established indications and agreed upon by the involved depart-
ments might have resulted in a decreased mortality rate.
We had no patients with VO caused by methicillin-resistant
Staphylococcus aureus (MRSA) so we were not able to con-
clude anything regarding the influence of drug resistance on
mortality or that VO caused by Staphylococcus aureus were
more severe than any other causative organism. This is possibly
a result of a very efficient tracking and eradication program for
MRSA in our region. Likewise, endocarditis was not a factor in
the predictive model. All patients with VO undergo both trans-
thoracic and transesophageal echocardiography at our institu-
tion—1 out of 7 had endocarditis. Prompt diagnosis and
treatment is probably the key word. Neurological deficits mea-
sured with the Frankel score did not find a place in the pre-
dictive model. However, some correlations existed between the
Frankel score and the Karnofsky score. The Frankel score is a
crude measure of neurological deficits with no grading of
muscle strength and does not register sphincter functions. Dia-
betes was not a significant factor influencing mortality in this
study though this has been associated with increased mortality
in other studies.29 No doubt the CCI functions as a container for
the different comorbidities, for example, diabetes, chronic
obstructive lung disease, and so on.
Figure 5 can be explained by the individual characteristics
of the specific patient.17 Patient 55 was a 70-year-old woman
who died 523 days after the time of diagnosis. She had cardi-
ovascular disease as well as kidney disease (CCI coded as 1).
She had thoracic infection. Karnofsky was coded as zero. CRP
was normalized 8 days after the start of treatment (0). In con-
trast, patient 24, a woman of 51 years, had no risk factors and
was alive 4634 days after the diagnosis. Patient 55 was treated
without surgery and patient 24 with surgery.
Can the current study give precise indications for the choice
between surgical or conservative treatment based on the 19
independent variables? This choice depends not only the mor-
tality but also on the quality of life after the different interven-
tions.2,24 What this study indicates is that there is no reason for
hesitation (late normalization of CRP was associated with
increased mortality) in using the aforementioned indications
for surgery even if the patient in question has some or even
considerable comorbidities.
Conclusion
Patients undergoing surgical management for VO according to
standardized and agreed-upon guidelines had no higher mor-
tality than those allocated to conservative treatment even
though the surgically treated patients had more comorbidities
and more severe disease. A LASSO penalized Cox regression
analysis found 5 nonzero coefficients; CCI, CRP normaliza-
tion, cardiovascular disease, thoracic infection and Karnofsky
score, which were associated with an increased mortality. The
predictive model can be used to predict survival profiles for
patients on an individual level with an acceptable certainty as
the AUC for the predictive model in this study was between
0.74 and 0.77.
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